Artificial Intelligence Is a Game Changer in Drug Discovery R&D

Timofei Ermak
Additional contact information
Timofei Ermak: Silica Corpora

A chapter in Innovation in Life Sciences, 2024, pp 15-29 from Springer

Abstract: Abstract Significant progress has been made in several areas of our lives within the last few decades: machine learning and artificial intelligence methods, data storage and transmission approaches, computational hardware, biotech, and drug discovery. All these advances combined unlock the potential for artificial intelligence to become a paradigm-shifting technology for drug discovery. Current obstacles in traditional drug discovery, the potential impact of AI on drug discovery, core differentiating factors of AI over traditional algorithms, and the latest advances in drug discovery with AI are discussed in this chapter.

Keywords: Drug discovery; Artificial intelligence; Machine learning; Biotech R&D; Drug design; Protein design (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:mgmchp:978-3-031-47768-3_2

Ordering information: This item can be ordered from
http://www.springer.com/9783031477683

DOI: 10.1007/978-3-031-47768-3_2

Access Statistics for this chapter

More chapters in Management for Professionals from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().